InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
+$0.35 today
- Market cap
- $293.89M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
Volume 0.16M
Average 0.16M
INFU Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
InfuSystem Holdings, Inc.AMEX: INFU
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities remains negative
Q1 FY2026 other non-current liabilities was $0, compared with $0 a year earlier.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Other non-current liabilities increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 19.63M USD
- Year-over-year change
- —
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.63M | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Non-current Liabilities vs competitors
How INFU compares with its peers on the latest reported figures
- INFU's Mar 2026 other non-current liabilities of $0 is the 2nd highest of the 3 companies compared; the peer median is $28.01M.
- Other non-current liabilities amounts to 0.0% of total assets for INFU, versus a peer median of 0.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $56.02M | -25.7% | -31.8% | 1.4% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding INFU) | $28.01M | -25.7% | -31.8% | 0.7% | |
Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 186K | 165K | 231K | 527K | 3.19M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 15.41M | 16.87M | 19.83M | 21.16M | 22.9M |
| Inventory | 3.94M | 4.82M | 6.4M | 6.53M | 5.39M |
| Other Current Assets | 2.54M | 2.92M | 4.16M | 3.96M | 4.86M |
| Total Current Assets | 22.07M | 24.78M | 30.62M | 32.17M | 36.34M |
| Property, Plant & Equipment (Net) | 48.64M | 48M | 45.95M | 9.4M | 7.54M |
| Goodwill | 3.71M | 3.71M | 3.71M | 3.71M | 3.71M |
| Intangible Assets | 10.93M | 8.44M | 7.45M | 6.46M | 6.87M |
| Long-term Investments | 41.97M | 44.21M | 0 | 44.54M | 0 |
| Tax Assets | 10.03M | 9.63M | 9.12M | 7.19M | 4.64M |
| Other Non-current Assets | (39.76M) | (39.37M) | 6.07M | 151K | 41.47M |
| Total Non-current Assets | 75.52M | 74.61M | 72.3M | 71.45M | 64.22M |
| Total Assets | 97.59M | 99.39M | 102.92M | 103.61M | 100.56M |
| Account Payables | 7.86M | 8.34M | 8.01M | 9.85M | 10.82M |
| Short-term Debt | 349K | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 9.63M | 0 | 0 | 0 |
| Other Current Liabilities | 4.69M | (6.8M) | 7.7M | 7.81M | 9.36M |
| Total Current Liabilities | 12.9M | 14.47M | 15.71M | 17.66M | 20.18M |
| Long-term Debt | 32.75M | 33.16M | 29.1M | 23.86M | 3.43M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 19.63M |
| Total Non-current Liabilities | 36.42M | 36.92M | 34.9M | 28.42M | 23.05M |
| Total Liabilities | 49.31M | 51.39M | 50.61M | 46.09M | 43.23M |
| Common Stock | 2K | 2K | 2K | 2K | 2K |
| Retained Earnings | (53.9M) | (59.34M) | (58.63M) | (57.46M) | (60.7M) |
| Accumulated OCI | 268K | 1.49M | 1.09M | 1.12M | 565K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 48.27M | 48M | 52.3M | 57.53M | 57.33M |
| Total Debt | 36.77M | 36.92M | 34.9M | 28.42M | 3.43M |
| Net Debt | 36.58M | 36.75M | 34.67M | 27.9M | 241K |
InfuSystem Holdings, Inc.
AMEX:INFU
Intrinsic Alpha fair value
Locked
Current Price
$14.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.